Bellevue Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22
Closed -$3.6K 471
2025
Q4
$3.6K Buy
22
+11
+100% +$1.72K ﹤0.01% 375
2025
Q3
$1.47K Buy
+11
New +$1.34K ﹤0.01% 464

Other funds holding RGEN

Bellevue Asset Management's RGEN Position: Q1 2026 in Review

Bellevue Asset Management sold out of Repligen (RGEN) in Q1 2026, closing a stake of 22 shares — an estimated $3.6K sold.

Bellevue Asset Management first reported a position in RGEN in Q3 2025 and held it in 2 quarters. The position peaked at $3.6K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Bellevue Asset Management reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Bellevue Asset Management sold 22 Repligen shares in Q1 2026, an estimated $3.6K.
  • Bellevue Asset Management first reported a position in Repligen in Q3 2025 and held it in 2 quarters.
  • Bellevue Asset Management's Repligen position peaked at $3.6K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Bellevue Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.